Bruce Power announces milestone in medical Lu-177 production

June 24, 2022, 12:01PMNuclear News
The new IPS installed in Bruce Power’s Unit 7 will produce Lu-177 for treating cancer. (Photo: Bruce Power)

An international collaboration between Bruce Power, Isogen (a joint venture of Kinectrics and Framatome), and ITM Isotope Technologies Munich SE, announced a milestone marking the first time that lutetium-177, a short-lived medical radioisotope, has been produced in a commercial nuclear power reactor.

CNSC, NRC complete joint report on the Xe-100 SMR

August 19, 2021, 12:00PMNuclear News

The Canadian Nuclear Safety Commission and the U.S. Nuclear Regulatory Commission have completed the first collaborative project under a two-year-old memorandum of cooperation (MOC) aimed at enhancing technical reviews of advanced reactor and small modular reactor technologies, the CNSC announced earlier this week.

The project, a 23-page joint report from the regulators on a white paper submitted last July by X-energy regarding reactor pressure vessel (RPV) construction code specifications for the company’s Xe-100 SMR, was released to the public on August 6. The Xe-100 is an 80-MWe unit that can be scaled into a “four-pack” 320-MWe power plant, according to X-energy.